Regulation of hypothalamic somatostatin, growth hormone-releasing hormone, and growth hormone receptor messenger ribonucleic acid by glucocorticoids.

Although it is well known that chronic treatment with glucocorticoids inhibits somatic growth, the mechanism of action of this inhibitory effect is not completely understood. It is likely that glucocorticoids act at various levels, including pituitary, hypothalamus, and peripheral organs modulating GH synthesis, secretion, and action. In this work, we evaluated the effect of dexamethasone on hypothalamic somatostatin and GH-releasing hormone (GHRH) messenger RNA (mRNA) levels by in situ hybridization. We found a significant decrease of somatostatin mRNA content in the periventricular nucleus of the hypothalamus after 3, 8, and 15 days of treatment with dexamethasone. Furthermore, we observed a reduction in GHRH mRNA levels in the arcuate nucleus after 8 and 15 days of treatment with this steroid. As it has been shown that GH feeds back to regulate somatostatin and GHRH expression at the hypothalamic level through high affinity GH receptors, we evaluated the possibility of a GH-mediated action in the inhibitory effect of glucocorticoids on somatostatin and GHRH mRNA levels. To address this issue, we first studied the GH receptor mRNA content in both the periventricular and arcuate nuclei of the hypothalamus after dexamethasone treatment. Secondly, the effect of dexamethasone on somatostatin and GHRH mRNA levels in hypophysectomized animals also was assessed. We found a significant decrease in GH receptor mRNA levels in the periventricular nucleus and in the arcuate nucleus after 1, 3, 8, and 15 days of glucocorticoid administration. Finally, in hypophysectomized rats, dexamethasone treatment for 15 days did not reduce somatostatin mRNA levels in the periventricular nucleus but significantly decreased GHRH mRNA content in the arcuate nucleus. In summary, our results suggest an inhibitory GH-mediated effect of dexamethasone on somatostatin mRNA levels in the periventricular nucleus and an inhibitory direct effect of dexamethasone on GHRH neurones in the arcuate nucleus.

[1]  I. Robinson,et al.  Hypothalamic GH receptor gene expression in the rat: effects of altered GH status. , 1995, The Journal of endocrinology.

[2]  J. Kamegai,et al.  Growth hormone induces expression of the c-fos gene on hypothalamic neuropeptide-Y and somatostatin neurons in hypophysectomized rats. , 1994, Endocrinology.

[3]  P. Emson,et al.  Distribution of Somatostatin Receptors 1, 2 and 3 mRNA in Rat Brain and Pituitary , 1994, The European journal of neuroscience.

[4]  D N Papachristou,et al.  Glucocorticoids regulate somatostatin peptide and steady state messenger ribonucleic acid levels in normal rat tissues and in a somatostatin-producing islet tumor cell line (1027B2). , 1994, Endocrinology.

[5]  L. Chung,et al.  Dexamethasone decreases somatostatin mRNA levels in the periventricular nucleus of the rat hypothalamus. , 1993, Neuroendocrinology.

[6]  K.,et al.  Growth hormone receptor messenger ribonucleic acid distribution in the adult male rat brain and its colocalization in hypothalamic somatostatin neurons. , 1992, Endocrinology.

[7]  J. Kamegai,et al.  Systemic administration of recombinant human growth hormone induces expression of the c-fos gene in the hypothalamic arcuate and periventricular nuclei in hypophysectomized rats. , 1992, Endocrinology.

[8]  A. Herington,et al.  Tissue distribution, characterization, and regulation of messenger ribonucleic acid for growth hormone receptor and serum binding protein in the rat. , 1991, Endocrinology.

[9]  P. Emson,et al.  Distribution of somatostatin mRNA in the rat nervous system as visualized by a novel non-radioactive in situ hybridization histochemistry procedure , 1990, Neuroscience.

[10]  K. Jones,et al.  Glucocorticoids: potent inhibitors and stimulators of growth hormone secretion. , 1990, Endocrinology.

[11]  P. Chomczyński,et al.  Cloning and characterization of mouse growth hormone-releasing hormone (GRH) complementary DNA: increased GRH messenger RNA levels in the growth hormone-deficient lit/lit mouse. , 1989, Molecular endocrinology.

[12]  J. Logan,et al.  The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor. , 1989, Genes & development.

[13]  J. Luo,et al.  Dexamethasone inhibits growth hormone induction of insulin-like growth factor-I (IGF-I) messenger ribonucleic acid (mRNA) in hypophysectomized rats and reduces IGF-I mRNA abundance in the intact rat. , 1989, Endocrinology.

[14]  P. Chomczyński,et al.  Feedback regulation of growth hormone (GH)-releasing hormone gene expression by GH in rat hypothalamus. , 1988, Molecular endocrinology.

[15]  L. Phillips,et al.  Glucocorticoid effects on somatomedins and somatomedin inhibitors. , 1985, The Journal of clinical endocrinology and metabolism.

[16]  W. Vale,et al.  Growth hormone-releasing factor binding sites in rat anterior pituitary membrane homogenates: modulation by glucocorticoids. , 1985, Endocrinology.

[17]  D. Moore,et al.  The first intron of the human growth hormone gene contains a binding site for glucocorticoid receptor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Lamberts,et al.  Human growth hormone-secreting pituitary adenoma cells in long-term culture: effects of dexamethasone and growth hormone releasing factor. , 1984, The Journal of endocrinology.

[19]  J. Vaughan,et al.  Effects of synthetic human pancreatic (tumor) GH releasing factor and somatostatin, triiodothyronine and dexamethasone on GH secretion in vitro. , 1983, Endocrinology.

[20]  R. Tushinski,et al.  Pregrowth hormone messenger RNA: glucocorticoid induction and identification in rat pituitary cells. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Loeb.  Corticosteroids and growth. , 1976, The New England journal of medicine.

[22]  R. Hill,et al.  Cartilage sulfation and serum somatomedin in rats during and after cortisone-induced growth arrest. , 1976, Endocrinology.

[23]  A. Tashjian,et al.  CONTROL OF GROWTH HORMONE PRODUCTION BY A CLONAL STRAIN OF RAT PITUITARY CELLS , 1969, The Journal of cell biology.

[24]  W. Bridson,et al.  Cortisol stimulation of growth hormone production by monkey adenohypophysis in tissue culture. , 1968, Biochemical and biophysical research communications.

[25]  D. Iezzoni,et al.  Effects of prolonged cortisone therapy on the statural growth, skeletal maturation and metabolic status of children. , 1956, The New England journal of medicine.

[26]  P. Emson,et al.  Evidence for the involvement of non-androgenic testicular factors in the regulation of hypothalamic somatostatin and GHRH mRNA levels. , 1996, Brain research. Molecular brain research.

[27]  I. Robinson,et al.  Steroid regulation of growth hormone (GH) receptor and GH-binding protein messenger ribonucleic acids in the rat. , 1995, Endocrinology.

[28]  W. Millard,et al.  Hormonal regulation of rat hypothalamic neuropeptide mRNAs: effect of hypophysectomy and hormone replacement on growth-hormone-releasing factor, somatostatin and the insulin-like growth factors. , 1991, Neuroendocrinology.

[29]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .